Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are incorporating the medicines into preconception care plans.
among people using glucagon-like peptide 1 receptor agonist drugs, and now fertility specialists are increasingly incorporating the medicines into preconception care plans.
The paper is timely and necessary because use of GLP-1s is only going to increase, said Patricia Jimenez, MD, an associate professor of obstetrics and gynecology at Washington University School of Medicine in St. Louis, Missouri, in an email to“GLP-1 RAs are becoming a larger part of my practice. More patients are either using them already or interested in using them,” said Jimenez, who is board certified in reproductive endocrinology, obstetrics and gynecology, and obesity medicine.
Small early studies on sperm are encouraging, Halpern said, suggesting that GLP-1 use may be beneficial, but a better understanding of direct effects is needed. The team is now working with an additional data set to examine exposed pregnancies among people with obesity, said Maya, an instructor of pediatrics at Mass General Hospital and Harvard School of Medicine. She is particularly interested in examining weight trajectories during pregnancy to see how they may affect fetal outcomes. Her team’s current project also will likely include analysis to examine other variables like postpartum weight gain and adiposity characteristics of the baby.
Diabetes Mellitus Type Ii Type 2 Diabetes Type 2 DM T2DM T2D Pregnancy Pregnant Fertility Obesity Obese Children Child Childhood Pediatrics Kids Weight Management Preconception Preconception Care Preconception Counseling Pre-Conception Preconception Counselling Weight Loss Contraception Birth Control Contraceptive Management Management Of Contraception
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Updates GLP-1 Label with Pulmonary Aspiration WarningThe new warning affects labels for drugs made with semaglutide, liraglutide, and tirzepatide.
Read more »
GLP-1 RAs Safe in the Perioperative Period: New GuidanceThe majority of patients may safely take glucagon-like peptide 1 receptor agonists before elective surgery and gastrointestinal endoscopies.
Read more »
This GLP-1 Supplement 'Helps Curb Cravings' — Get It for 42% OffThe supplement supports the gut while helping you maintain healthy weight thanks to its effective formula consisting of hops, green tea extract and more.
Read more »
Battle Continues Over Compounded GLP-1sNovo Nordisk seeks to put a stop to semaglutide compounding, whereas the FDA agrees to allow compounding of tirzepatide, for now.
Read more »
Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 MedsAs the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.
Read more »
GLP-1 RAs Reduce Early-Onset Colorectal Cancer Risk in Patients With Type 2 DiabetesA large retrospective study, the first of its kind, reported reduced rates of EO-CRC in patients younger than 50 years of age taking the antidiabetic medications.
Read more »